Comunicati.net - Comunicati pubblicati - SAI Comunicati.net - Comunicati pubblicati - SAI Fri, 28 Feb 2020 11:28:02 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://content.comunicati.net/utenti/24511/1 Global Graves Orbitopathy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:16:23 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/pd_partito_democratico/481535.html http://content.comunicati.net/comunicati/societa_civile/partiti/pd_partito_democratico/481535.html SAI SAI Global Graves Orbitopathy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Graves Orbitopathy Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Graves’ ophthalmopathy is also called as thyroid-associated orbitopathy (TAO) and thyroid eye disease (TED), Graves’ orbitopathy (GO) is autoimmune inflammatory disorder of the tissues of periorbit and orbit that is characterized by the retraction of upper eyelid, lagging, swelling and redness of lid, bulging of eyes and conjunctivitis. Most commonly occurs in the individuals having Graves’ disease, and less commonly in the individuals having Hashimoto’s thyroiditis, or in the people with euthyroid. It is a part of systemic process of variable expression in skin, thyroid and eyes that is caused by the autoantibodies which binds to the tissues of these organs. Autoantibodies targets the fibroblasts in the eye muscles and fibroblasts can be differentiated into the fat cells (adipocytes). Muscles and fat cells expands and gets inflammation.

 

Increase in incidence and prevalence of thyroid disorders, availability of appreciative reimbursement policies for the treatment, and growing awareness regarding the complications related to thyroid disorders are some of the factors driving Graves’ disease market. Side effects associated with drugs are one of the restraints for the graves orbitopathy market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-graves-orbitopathy-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The global graves orbitopathy market is segmented on the basis of drug class, distribution channel and geographical regions.

 

Based on the drug class, the graves orbitopathy market is segmented as:

·         Iodine and Iodides

·         Ionic Inhibitors

·         Radioactive Iodine

·         Beta Blockers

·         Thioamides

·         Corticosteroids

 

Based on the distribution channel, the graves orbitopathy market is segmented as:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-graves-orbitopathy-market/#ulp-c654SbFYO64MsOhu

 

 

As per Wickham study in England, in 2016, Graves’ disease is accounted for 0.5 cases per 1000 persons, with high incidence rate in people with age of 40 to 60. Graves’ disease is the high prevalent autoimmune disorder in U.S After Hashimoto thyroiditis. In 2016, as per research study of PREGO (presentation of Graves orbitopathy), incidence of Graves’ orbitopathy in Europe was 10-30/10,000 human annually. However, severity and the incidence of the Graves’ disease in Europe was observed to decline to 2.10/10,000/year. Iodine-131 is used in radioactive iodine ablation (RIA) used to remove whole or a part of thyroid gland, which results in preventing the excessive production of thyroid hormone. Subtotal thyroidectomy used for the removal of thyroid gland is the most invasive treatment option.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-graves-orbitopathy-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

On the basis of geographical regions, the graves’ orbitopathy market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected as major market for the disorders related to thyroid gland followed by Europe. Asia-Pacific is expected to be as a rapidly growing market due to rise in thyroid gland disorders, rise in health care investments, growing awareness regarding hyperthyroidism, and different alternative treatments availability.

 

Some of the players in the graves orbitopathy disease market are GlaxoSmithKline plc (U.K.), Allergan, plc.(Ireland) Abbott Laboratories (U.S.) RLC LABS (U.S.), AbbVie, Inc.( U.S.), Mylan N.V.( U.S.), Pfizer, Inc. (U.S.), and Merck & Co.,Inc. (U.S.).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-graves-orbitopathy-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Glaucoma Surgery Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:16:05 +0200 http://content.comunicati.net/comunicati/arte/musica/rock/481534.html http://content.comunicati.net/comunicati/arte/musica/rock/481534.html SAI SAI Global Glaucoma Surgery Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Glaucoma Surgery Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Glaucoma disease causes due to increase in intraocular pressure within the eye that damages the optic nerve and leads to loss of vision and even blindness. Glaucoma is second leading cause of irreversible blindness in the world. The most common types of glaucoma are open angle glaucoma and closed angle glaucoma. The common symptoms associated with glaucoma include eye pain, blurred vision, red eyes, light appears to extra halo-like glow around it, and vision problems with poor lighting. Glaucoma can be diagnosed by determining the intraocular pressure, the status of optic nerve and drainage angle, and visual fields. Glaucoma can be treated by using eye drops, laser treatments, and surgery.

 

The global glaucoma surgery market is expected to grow at a significant CAGR due to increase in the geriatric population as they are more prone to eye diseases. Rise in prevalence of glaucoma, new developments in minimally invasive glaucoma surgical devices, and increase in prevalence of diabetes and diabetic retinopathy expected to fuel the global glaucoma surgery market over the forecast period. Furthermore, changing lifestyle, unhealthy food, increase in incidence of ocular disorders, improved medical coverage, and increase in healthcare expenditure expected to bolster the global glaucoma surgery market. However, lack of awareness among key stakeholders about eye disorders, dearth of skilled professionals for glaucoma surgeries, stringent regulatory policies, and high cost of glaucoma surgery might hamper the growth of global glaucoma surgery market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-glaucoma-surgery-market/#ulp-4H8Z4LpNMLEuOnnx

 

 The glaucoma surgery market is segmented on the basis of disease type, surgery type, and end user

 

Based on surgery type, glaucoma surgery market has been segmented into the following:

·        Trabeculoplasty

·        Filtering surgery (viscocanalostomy)

·        Drainage implant (aqueous shunt implant)

·        Iridotomy

·        Others

 

Based on disease type, glaucoma surgery market has been segmented into the following:

·        Open-angle glaucoma

·        Closed-angle glaucoma

·        Low-tension glaucoma

·        Pigmentary glaucoma

·        Others

 

Based on end-user, glaucoma surgery market has been segmented into the following:

·        Hospitals

·        Ophthalmology Clinics

·        Ambulatory surgical centers

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-glaucoma-surgery-market/#ulp-c654SbFYO64MsOhu

 

Market players are adopting different strategies to increase their market share in the glaucoma surgery market. Acquisitions & mergers, collaborations, technological developments such as inserting implants by minimally invasive surgical procedures, and organizing training programs for physicians regarding glaucoma surgeries expected to bolster the global glaucoma surgery market. For instance, in September 2016, Johnson & Johnson acquired Abbott Medical Optics business segments that include laser refractive surgery, cataract surgery, and consumer eye health. In December 2016, Ellex Medical Lasers conducted clinical training for physicians about operation of Ellex iTrack minimally invasive glaucoma surgery device in China. Moreover, approval of new products from various administrative bodies also propel the glaucoma surgery market growth. For instance, in March 2016, Glaukos Corporation announced that the company’s trabecular micro-bypass stent named iStent was approved in Japan by Japanese Ministry of Health, Labor and Welfare (MHLW). In August 2016, Alcon received FDA approval for the CyPass a micro-invasive surgical device to treat open-angle glaucoma. In the near future, pipeline products that can treat glaucoma are expected to create significant opportunities for the device manufacturers.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-glaucoma-surgery-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically, the global glaucoma surgery market segmented into the following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share followed by Europe and Asia-Pacific. North America holds dominant share in glaucoma surgery market which is mainly attributed to the availability of skilled professionals, increase in the incidence of glaucoma patients (according to Glaucoma Research Foundation survey, approximately one out of 10,000 babies born with glaucoma in United States), and increase in healthcare expenditure. Europe market is growing at significant CAGR owing to increase in the prevalence of glaucoma disease. In Europe, Italy has the highest prevalence for glaucoma disease that is approximately 182 prevalent cases per 100,000 population. Austria, Spain, and Germany also play a key role in Europe glaucoma surgery market due to the increase in prevalence cases. Asia-Pacific holds a key share due to increase in the geriatric population, rise in the prevalence of glaucoma disease patients majorly in India, China, and Japan.

 

Some of the players in glaucoma surgery market are Glaukos Corporation (U.S.), Ellex Medical Lasers (Australia), DOSE Medical Corporation (U.S.), Johnson & Johnson Services Inc., (U.S.), Abbott Laboratories (U.S.), and Alcon (Novartis) (U.S.) to name a few.

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

]]>
Global Genetic Analyzer Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:15:53 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/radicali/481533.html http://content.comunicati.net/comunicati/societa_civile/partiti/radicali/481533.html SAI SAI Global Genetic Analyzer Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Genetic Analyzer Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Genetic analysis is a method of learning and research in genetics and molecular biology fields that involves use of wide group of applications while basic system of the analysis is usually pertained to the orthodox genetics. Customary forms of analysis of genetic includes the gene identification and inherited diseases analysis. Genetic analysis also implicit the patients physical observation and the microscopic evaluation of genetics as it is conducted for the long time. Genetic analysis is also applied in differential diagnosis during the analysis of specific diseases, in mutation detection, copy number changes in DNA.

 

Factors like advancements in the technologies of genetic testing, rise in prevalence of the genetic diseases, growing in the awareness are boosting the genetic analyser market globally. Furthermore, initiatives taken by the governments and increase in R&D investment and activities in the genetic field are also driving the genetic analyzer market. However, due to certain factors genetic analyzers use is restricted. The operability of such kind of automated advanced machines requires technical expertise leaving little room for human error. Calibration is essentially needed for genetic analyzers. High cost of genetic analyzers resulting in their availability in a limited number of research organizations is also hampering the growth of the genetic analyzers market globally.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Global genetic analyzer market is segmented on the basis of instruments, consumables, application, end-user and geographical regions.

 

Based on product type, global genetic analyzer market is segmented as:

·         Instruments

o    DNA Microarrays

o    PCR

o    Next Generation Sequencing

o    Serial Analysis of Gene Expression

o    Northern Blotting

·         Consumables

o    DNA Chips

o    Reagents

 

Based on the end-user, global genetic analyzer market is segmented as:

·         Diagnostics Centres

·         Drug Discovery

·         Research and Development

·         Others

 

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-c654SbFYO64MsOhu

 

 

Increase in the clinical genome sequencing, increase in incidence of neurodegeneration diseases such as Alzheimer’s, Huntington’s and Parkinson’s disease and also cases of cancers prompts the interest in genetic analysis. High swift in the acceptance of pediatric genetic testing used for of screening adult onset disorders are the factors contributing to the genetic analyzer market growth. Some of the government initiatives are improving the healthcare delivery to different sections of population, mergers, acquisitions and product launches of the companies are the factors driving the growth of the genetic analyzer market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, genetic analyzer market is divided into Europe, Asia-Pacific North America, Latin America, and Middle East and Africa. Global genetic analyser market is dominated by North America due to the rise in diseases prevalence by genetic disorders and rise in advancements technologically in the region. Asia-Pacific, is expected to show significant growth during the forecast period in the genetic testing market. India, China and Japan are expected as the fastest growing genetic testing markets in the Asia-Pacific region due to increase in R&D investment, a large pool of patients and rising government funding.

 

Some of the major companies dealing in genetic testing market are Thermo Fisher Scientific Inc. (U.S.), BioRad Laboratories (U.S.), Abbott laboratories (U.S.), AutoGenomics Inc.( U.S.), Celera Group (U.S.), PerkinElmer Inc.( U.S.), Quest Diagnostics Inc.( U.S.), ELITech Group (U.S.), Applied Biosystems Inc.( U.S.), F. Hoffmann-La Roche AG (Switzerland), Transgenomic Inc.( U.S.).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/

 

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Genetic Analyzer Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:15:51 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/radicali/481532.html http://content.comunicati.net/comunicati/societa_civile/partiti/radicali/481532.html SAI SAI Global Genetic Analyzer Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Genetic Analyzer Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Genetic analysis is a method of learning and research in genetics and molecular biology fields that involves use of wide group of applications while basic system of the analysis is usually pertained to the orthodox genetics. Customary forms of analysis of genetic includes the gene identification and inherited diseases analysis. Genetic analysis also implicit the patients physical observation and the microscopic evaluation of genetics as it is conducted for the long time. Genetic analysis is also applied in differential diagnosis during the analysis of specific diseases, in mutation detection, copy number changes in DNA.

 

Factors like advancements in the technologies of genetic testing, rise in prevalence of the genetic diseases, growing in the awareness are boosting the genetic analyser market globally. Furthermore, initiatives taken by the governments and increase in R&D investment and activities in the genetic field are also driving the genetic analyzer market. However, due to certain factors genetic analyzers use is restricted. The operability of such kind of automated advanced machines requires technical expertise leaving little room for human error. Calibration is essentially needed for genetic analyzers. High cost of genetic analyzers resulting in their availability in a limited number of research organizations is also hampering the growth of the genetic analyzers market globally.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Global genetic analyzer market is segmented on the basis of instruments, consumables, application, end-user and geographical regions.

 

Based on product type, global genetic analyzer market is segmented as:

·         Instruments

o    DNA Microarrays

o    PCR

o    Next Generation Sequencing

o    Serial Analysis of Gene Expression

o    Northern Blotting

·         Consumables

o    DNA Chips

o    Reagents

 

Based on the end-user, global genetic analyzer market is segmented as:

·         Diagnostics Centres

·         Drug Discovery

·         Research and Development

·         Others

 

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-c654SbFYO64MsOhu

 

 

Increase in the clinical genome sequencing, increase in incidence of neurodegeneration diseases such as Alzheimer’s, Huntington’s and Parkinson’s disease and also cases of cancers prompts the interest in genetic analysis. High swift in the acceptance of pediatric genetic testing used for of screening adult onset disorders are the factors contributing to the genetic analyzer market growth. Some of the government initiatives are improving the healthcare delivery to different sections of population, mergers, acquisitions and product launches of the companies are the factors driving the growth of the genetic analyzer market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, genetic analyzer market is divided into Europe, Asia-Pacific North America, Latin America, and Middle East and Africa. Global genetic analyser market is dominated by North America due to the rise in diseases prevalence by genetic disorders and rise in advancements technologically in the region. Asia-Pacific, is expected to show significant growth during the forecast period in the genetic testing market. India, China and Japan are expected as the fastest growing genetic testing markets in the Asia-Pacific region due to increase in R&D investment, a large pool of patients and rising government funding.

 

Some of the major companies dealing in genetic testing market are Thermo Fisher Scientific Inc. (U.S.), BioRad Laboratories (U.S.), Abbott laboratories (U.S.), AutoGenomics Inc.( U.S.), Celera Group (U.S.), PerkinElmer Inc.( U.S.), Quest Diagnostics Inc.( U.S.), ELITech Group (U.S.), Applied Biosystems Inc.( U.S.), F. Hoffmann-La Roche AG (Switzerland), Transgenomic Inc.( U.S.).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-genetic-analyzer-market/

 

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Generic Drugs Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:15:36 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/italia_dei_valori/481531.html http://content.comunicati.net/comunicati/societa_civile/partiti/italia_dei_valori/481531.html SAI SAI Global Generic Drugs Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Generic Drugs Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

A generic drug is pharmaceutical drug product that is bio equivalent to the branded drug. Bioequivalence means there is no significant difference between the two drugs in terms of safety, efficacy and administration. Generic drugs are usually approved after patent expiration of the innovator drugs. One example of a well-known generic drug is metformin that is used to lower blood sugar levels in diabetes. Metformin is the generic form of a drug that is available under the brand name Glucophage.

 

Global generic drugs market is driven by the prevalence of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favourable regulatory policies, expiry of the branded drugs, and growth in biosimilars segment are expected to boost the generics drugs market. Furthermore, participants in the supply chain such as wholesalers, retailers and pharmacies also benefit from the sale of the generic drugs with high margins compared to branded generics. This emerged as key driver for the growth of global generic drugs market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Generic Drugs market segmented based on therapeutic area and distribution channel

 

Based on therapeutic area, global generic drugs market is segmented into

·         Cardiovascular

·         CNS

·         Antibiotics

·         Oncology

·         Gastrointestinal

·         Hormones

·         Pain Management

·         Others

 

Based on distribution channel, global generic drugs market is segmented into

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-c654SbFYO64MsOhu

 

 

Generic drugs market is highly fragmented market, presence of large players and small players. To improve their market position in generic drug market companies are adopting strategies like expanding their market presence through collaboration and entering into new markets. For instance, in January 2017, Medical inhaler company Vectura Group PLC collaborated with Sandoz, a division of Novartis AG, to develop a generic version of an inhaler therapy for asthma and COPD (chronic obstructive pulmonary disease). In January 2016, Momenta collaborated with Mylan Laboratories for the development, manufacture and commercialization of six of its biosimilar candidates, including M834, Orencia (abatacept) a biosimilar candidate. Mergers and acquisitions are key strategies adopted by various market players. For instance, in August 2016, Teva Pharmaceutical Industries Ltd Acquired Allergen’s generic business Actavis Generics to expand their product, R&D portfolio and geographical footprint in generic market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically generic drugs market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America generic drugs market is expected to grow at significant rates owing to availability of more number of generics, increase awareness about the generic drugs and favourable regulatory policies and acts such as Affordable Care Act 2010. In Europe region, Belgium and UK expected to grow at notable rates owing to prevalence of chronic diseases, increase in investment on biosimilars, and increase awareness about generic drugs. Asia Pacific Region expected to be fastest growing due to increased government initiatives in usage of generic drugs and increase in awareness about generic drugs. Especially emerging countries like India government initiating different policies and schemes to boost the usage of generic drugs, For instance, Government of India taken an initiative of opening Jan aushadhi stores to make available quality generic medicines at affordable prices to all citizens.

 

Some of the market players in generic drugs market are Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries, Ltd. (Israel), Dr Reddy’s Laboratories (India), Novartis AG (Sandoz International GmbH) (Switzerland), Apotex Holdings Inc. (Canada), Endo International plc (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc., (Janssen Pharmaceutica) (U.S.), Lupin Limited (India), Merck & Co, Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Nexus Pharmaceuticals (U.S.), and Novo Nordisk (Denmark) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/

]]>
Global Gene Editing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:15:19 +0200 http://content.comunicati.net/comunicati/arte/musica/new_age/481530.html http://content.comunicati.net/comunicati/arte/musica/new_age/481530.html SAI SAI Global Gene Editing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Gene Editing Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

 

Gene editing or Genome editing is the type of genetic editing where DNA is inserted, replaced or deleted in the genome of an organism in order to treat a specific disease by using a molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in genome. The induced double-stranded breaks are repaired through nonhomologous end joining or homologous recombination resulting in targeted mutations (edits).

 

Rise in the prevalence rate of cancer & other genetic disorders, increasing preference in the personalized medicine, companies investments towards R&D, and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and gene editing technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genome editing market. However, global gene editing market is hindered by stringent government regulations to approve gene mutation projects, ethical issues, unavailability of gene editing based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/#ulp-c654SbFYO64MsOhu

 

 

The gene editing market segmented based upon applications, technology, end-user, products, and region.

 

On the basis of technology, global genome editing market is segmented as:

·         Zinc Finger Nuclease (ZFN)

·         Clustered regularly interspaced short palindromic repeats (CRISPR)

·         Transcription activator-like effector nuclease (TALEN)

·         Others

 

On the basis of application, global genome editing market is segmented as:

·         Cell Line Editing

·         Targeted gene mutation

·         Animal Genome Editing

·         Plant Genome Editing

On the basis of product type, global genome editing market is segmented as:

·         Consumables

·         Instruments and Software

 

On the basis of end-user, Global Genome Editing Market is segmented as:

·         Pharmaceutical companies

·         Biotechnology Companies

·         Academics

·         Clinical Research Organizations

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/#ulp-c654SbFYO64MsOhu

 

 

Biotechnology and pharmaceutical sectors dominate gene editing market due to its applications in drug discovery and therapeutics. Rise in usage of CRISPR and ZFN, companies are investing on innovative research for development of novel gene editing techniques. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers and acquisitions, strategic or manufacturing activities are driving the growth of genome editing market. For instance, in 2014, Thermo Fisher acquired Life technologies, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets.In 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/#ulp-14mlyhjMGhVjZqa3

 

 

On the basis of Geographical regions, the genome editing market categorized into five regions:, Europe, North America, Latin America, Asia Pacific, and Middle East & Africa. The gene editing market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the gene editing market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems, the expansion of leading genome editing companies and increased R&D spending.

 

Some of the players in genome editing market are Cellectis S.A. (France), Applied Stemcell, Inc. (U.S.),  Genscript (U.S.), Merck KGaA (Germany), Horizon Discovery Group plc,(U.K.), Origene Technologies, Inc. (U.S.), System Biosciences, Inc. (U.S.), Sangamo Therapeutics, Inc.(U.S.), Thermo Fisher Scientific (U.S), and Transposagen Biopharmaceuticals, Inc.(U.S.).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/

]]>
Global Gastric Balloons System Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:15:03 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/italia_dei_valori/481529.html http://content.comunicati.net/comunicati/societa_civile/partiti/italia_dei_valori/481529.html SAI SAI Global Gastric Balloons System Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Gastric Balloons System Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

 

Gastric balloon system is an innovative non-surgical weight loss procedure in which physicians temporarily places gastric balloon in stomach. Gastric balloon system will be placed in stomach using endoscopy through esophagus and some of the products are in swallowable capsule form. With the help of gastric balloons patient feel fluffiness and it enables reduce the weight. Gastric balloon system is used for patients only when diet and exercise have failed in reducing weight and surgery is not wanted or recommended to patient.

 

According to WHO Global Health Observatory data, 2014 more than 1.9Bn people worldwide and nearly one-quarter of children, adolescents in developed countries are overweight or obese. At least 2.8Mn people each year die as result of overweight or obese and half of the world’s population may be subjected to obesity by 2030. Moreover, increase in the awareness about the consequences related to obesity and chances of getting the other chronic diseases, patients are preferring to lose weight. Apart from fore mentioned factors, advances in gastric balloon technology led to more safe and cost effective procedure over the surgical procedures. Along with this, short hospital stay, reducing recovery time, expected to prompt healthcare professionals to choose the gastric balloon systems over other bariatric procedures. However the adverse events associated with gastric balloon systems such as inflation of balloon, pain, swelling, vomiting, and chances of getting acute pancreatitis are becoming as restrains for gastric balloon system market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gastric-balloons-system-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Gastric balloon system market is segmented based upon product, mode of administration, filling material and end user.

 

Based on product, gastric balloon system market is segmented into

·         Single Intra Gastric Balloon

·         Double Intra Gastric Balloon

·         Triple Intra Gastric Balloon

 

Based on filling material, gastric balloon system market is segmented into

·         Saline Filling

·         Gas Filling

 

Based on route of administration, gastric balloon system market is segmented into

·         Endoscopy

·         Swallowable

 

Based on end user, gastric balloon system market is segmented into

·         Hospitals

·         Bariatric Clinics

·         Ambulatory Surgical Centers

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gastric-balloons-system-market/#ulp-c654SbFYO64MsOhu

 

 

Gastric balloon system is in growth phase, fluid filled gastric balloon products are having prevalent adverse events when compared to the gas filled products. In February 2017, U.S. FDA alerted healthcare providers stating about the high prevalence of adverse events with the usage of fluid filled gastric balloons. Due to the advancements in technology like development of swallowable capsules forms by Obalon technologies (obalon) and Allurion (elipse), and reducing the risks in using gastric balloon systems are increasing the acceptance of gastric balloon system products by patients. These factors are expected to bolster revenue growth of gastric balloon system market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-gastric-balloons-system-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among all the regions North America accounts larger share due to more number of obese patients. According to Centers for Disease Control and Prevention (CDC), more than 36% of the US adult population is obese.  In Europe increasing prevalence of the obesity and rising demand for weight loss products driving the market revenue growth. Gastric balloon system market in Latin America is growing at significant CAGR due to rapid increase in healthcare expenditure and increase in number of doctors. In Asia-Pacific region because of rise in the medical tourism, lower cost of healthcare, and rise in development of healthcare infrastructure in developing countries like India projects the better growth opportunity for Gastric balloon system market players.

 

Some of the players in global gastric balloon system market are Allurion Technologies (U.S.), Silimed inc. (Brazil), Obalon Therapeutics Inc. (U.S.), Districlass Medical (S.A.) (France), and ReShape Medical Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-gastric-balloons-system-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Gamma Knife Devices Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:14:48 +0200 http://content.comunicati.net/comunicati/arte/musica/lirica/481527.html http://content.comunicati.net/comunicati/arte/musica/lirica/481527.html SAI SAI Global Gamma Knife Devices Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Gamma Knife Devices Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

 

Gamma knife is one type of radiological surgery device which acts by focusing on low-dosage gamma radiation from various sources on accurate target. Gamma knife devices are used for treating metastatic brain tumours in brain from the sites like breast, lung, and skin, vascular malformations of brain, acoustic neuromas, meningioma’s tumors on the protective layers of the brain, trigeminal neuralgia causes severe facial pain and epilepsy of temporal lobe.

 

Gamma knife devices market is propelling by the increase in demand of non-invasive procedures, rise in the prevalence of brain cancers, and rise in ageing of population globally. In addition, high success rate of gamma knife treatment, short recovery period, favorable health insurance policies, high government initiatives, growing awareness on radiation therapy are anticipated to boost the gamma knife devices market. However, stringent regulations for the approval of the radiation devices, high cost for gamma knife devices and lack of awareness in developing regions are expected to hinder the gamma knife devices market. Gamma knife device many alternative therapies namely cyber knife, linac radiosurgery, conventional brain surgery, proton therapy, and modified linear accelerators. Moreover, lack of skilled healthcare professionals to use the radiation devices and side effects of radiation therapy further hampering the growth of the gamma knife devices market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gamma-knife-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Gamma knife devices market segmented based on application, anatomy, and end user

 

Based on application, gamma knife devices market is segmented into

·         Arteriovenous Malformations

·         Trigeminal Neuralgia

·         Cancer

·         Brain Metastases

·         Others

 

Based on anatomy, gamma knife devices market is segmented into

·         Head

·         Neck

·         Others

 

Based on end-user, gamma knife market is segmented into

·         Hospitals

·         Ambulatory Radiotherapy Centres

·         Cancer Research Institutes

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-gamma-knife-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Gamma knife devices market expected to grow at significant CAGR rate during the forecast period. Market players are expanding their market presence by entering into new markets. For instance, in February 2017, Elekta’s received Medical Devices License from Health Canada for its Leksell Gamma Knife Icon radiosurgery system, the only stereotactic radio surgery SRS system designed specifically to target brain tissue. Product developments and new product launches are market strategies adopted by the market players.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-gamma-knife-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically Gamma knife devices market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be a major contributor for gamma knife devices market due to increased demand for radiological surgeries. In addition, favourable reimbursement policies and increase in awareness about radiation therapy are boosting the gamma knife devices market. Asia-Pacific region projecting lucrative opportunities for growth of gamma knife devices market owing to developing healthcare infrastructure, increase in awareness about radiotherapy surgeries and increase in prevalence of the neurological diseases. Adoption of cutting-edge technologies, rise in the medical tourism in emerging nation in Asia Pacific expected to fuel the market. Countries like China, Japan and India expected to be major markets in Asia Pacific Region. Latin America is offering lucrative opportunities for gamma knife devices market owing to increase in R&D investments in the manufacturing of radiosurgery equipment.

 

Some of the market players in gamma knife devices market are Elekta AB (Sweden), Varian Medical Systems, Inc. (U.S), Huiheng Medical, Inc. (China), Masep Infini Global, Inc. (U.S.), and Nordion, Inc. (Canada), to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-gamma-knife-devices-market/

]]>
Global Foot And Ankle Devices Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:14:32 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/alleanza_nazionale/481526.html http://content.comunicati.net/comunicati/societa_civile/partiti/alleanza_nazionale/481526.html SAI SAI Global Foot And Ankle Devices Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Foot And Ankle Devices Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Foot and ankle devices are used for the treatment of heal injuries and disorders in the foot and ankle region with or without the help of surgical procedures. On the other hand, injuries caused by orthopaedic disorders, such as bunions, arthritis, diabetic foot, and hammertoes which may call for surgical procedures with the subsequent use of foot and ankle devices. These devices are also used in replacement of foot lost or foot damage due to, trauma, amputation, and congenital conditions. Technological developments made these devices as stronger and lighter, and restrict the additional energy applied by the organ.

 

The foot and ankle devices market is growing at a significant CAGR due to increase in population and road accidents. Increase in bone injury cases among adults with diabetes and vascular disease leads to deterioration of the foot-ankle area and infections caused due to the poor circulation of blood, and rise in the incidence of injuries owing to major accidents and sports are expected to fuel the foot and ankle devices market over the forecast period. Moreover, technological developments such as increased battery life and more shock absorption, introduction of microprocessor controlled prosthetic feet have increased the comfort level of patients and is thus gaining popularity which is expected to propel the foot and ankle devices market growth. However, the high cost of some of the foot and ankle devices, lack of trained professionals, and implied excise tax on medical devices are a few of the primary factors hamper the future growth of foot and ankle devices market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foot-and-ankle-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The global foot and ankle devices market is segmented based on the product type, cause of injury, and end-user

 

Based on product type, foot and ankle devices market has been segmented into the following:

·         Prostheses

·         Microprocessor-controlled prostheses

·         Solid ankle cushion heel foot

·         Dynamic response or Energy-storing prostheses

·         Multiaxial prostheses

·         Single-axial prostheses

·         Bracing and supporting devices

·         Hinged braces

·         Soft bracing

·         Orthopaedic devices and implants

·         Soft-tissue orthopaedic devices

·         Artificial tendons & ligaments

·         Musculoskeletal reinforcement devices

·         Joint implants

·         Phalangeal implants

·         Ankle implants (ankle replacement devices)

·         Subtalar joint implants

·         Fixation devices

·         Internal fixation Fusion nails

·         Screws

·         Wires & pins

·         Plates

·         External fixation Ring ankle fixators

·         Unilateral fixators

·         Hybrid fixators

 

Based on the cause of the injury, the foot and ankle devices market is segmented into the following:

·         Neurological disorders

·         Trauma

·         Diabetes

·         Other causes

 

Based on end-user, the foot and ankle devices market is segmented into the following:

·         Hospitals

·         Clinics

·         Rehabilitation centre

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foot-and-ankle-devices-market/#ulp-c654SbFYO64MsOhu

 

 

The foot and ankle devices able to repair the ligament and reconstruction procedures such as arthrodesis, joint replacement, and internal fixation. Foot-ankle extremities are a key revenue contributor to the global foot and ankle devices market. The most commonly adopted strategies by industry players include new product launches with technological innovations, acquisitions & mergers, agreements, and collaborations to capture significant foot and ankle devices market share. For instance, in September 2015, Integra Life Sciences acquires Tornier foot & ankle products ahead of Wright Medical merger to increase its foot and ankle devices market share outside the United States. Similarly, in May 2013, Wright Medical introduced Ortholoc 3Di with screw technology and redesigned plates for multiple applications in foot and ankle devices market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foot-and-ankle-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically, foot and ankle devices market has been segmented into following regions Viz. North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. U.S. foot and ankle devices market is anticipated to dominate the market share in the near future. North America is expected to hold the dominant share in the foot and ankle devices market followed by Europe and Asia-Pacific. Increase in the sports injuries, rising prevalence rate of diabetes and arthritis (according to the National Health Interview Survey (NHIS), approximately 22.7% of adults in the U.S. are diagnosed with arthritis every year), and entry of new products into the market might fuel the growth of foot and ankle devices market in North America region. Europe accounts for the second largest share in foot and ankle devices market attributed to the entry of new devices to treat foot and ankle disorders, expansion and penetration in Europe countries are key drivers for the growth of foot and ankle devices market. Asia-Pacific market is growing at a significant CAGR owing to increase in aging population rise in the sports injuries, the higher acceptance rate for advanced technologies, and rising cases of road accidents in the Asia-Pacific region.

 

Some of the players in foot and ankle devices market are Stryker (U.S.), Smith & Nephew (U.K.), Zimmer Biomet (U.S), Arthrex, Inc. (U.S.), Wright Medical Group N.V. (U.S.), Mondeal Medical Systems GmbH (Germany), Integra LifeSciences Corporation (U.S.), Extremity Medical (U.S), and De Puy Synthes (Johnson & Johnson) (U.S.), and to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foot-and-ankle-devices-market/

 

 

 

]]>
Global Foodborne Diseases Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:14:19 +0200 http://content.comunicati.net/comunicati/turismo/varie/481525.html http://content.comunicati.net/comunicati/turismo/varie/481525.html SAI SAI Global Foodborne Diseases Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Foodborne Diseases Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

 

Foodborne diseases cover a broad spectrum of illnesses that are affecting the people worldwide. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals. The contamination occurs from any way either soil, water or air. The most common foodborne infections are caused by three bacteria campylobacter, salmonella, and E.coli and by a group of viruses called calicivirus. Clinical symptoms of foodborne diseases seen in gastro intestinal tract. Symptoms include vomiting, diarrhea, and abdominal pain. In some cases, such diseases can also have neurological, gynecological, immunological and other symptoms. Common foodborne diseases include botulism, salmonellosis, traveler’s diarrhoea, gastroenteritis, tapeworm infection and hepatitis A, among others.

 

Global foodborne diseases treatment market is driven by the increasing incidence of foodborne diseases worldwide. In addition, increase in R&D investment, growing awareness about foodborne disease symptoms due to initiatives of government and non-government organizations such as WHO, and lack of hygiene conditions are boosting the foodborne diseases treatment market worldwide. However, the high cost of R&D investment for development of anti microbial and stringent, time-consuming regulatory procedures are expected to hinder the foodborne diseases market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Foodborne diseases treatment market has been segmented based on disease, drug class, and distribution channel

 

Based on drug class, foodborne diseases treatment market is segmented into

·         Antibiotics

·         Anti Diarrhea

·         Fluids and Electrolyte Replenishers

·         Vaccines

·         Others

 

Based on disease, foodborne diseases treatment is segmented into

·         Botulism

·         Traveler’s Diarrhea

·         Gastroenteritis

·         Toxoplasmosis

·         Others

 

Based on route of administration, foodborne diseases treatment market is segmented into

·         Parenteral

·         Oral

·         Others

 

Based on distribution channel, foodborne diseases treatment market is segmented into

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

·         Drug Stores

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-c654SbFYO64MsOhu

 

Foodborne diseases treatment market is expected to grow at significant CAGR during the forecast period. According to the findings of WHO – “Estimates of the global burden of foodborne diseases” 2015, almost 1 in every10 people fall ill yearly due to contaminated food consumption and 420,000 deaths occour as a result. Market players are adopting drug developments and collaborations as key market strategies.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically Foodborne Diseases Treatment Market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America foodborne diseases treatment market is expected to grow at notable rates due to increase in the prevalence of foodborne diseases such as botulism and toxoplasmosis, and increase in R&D investment by companies on antibiotics and vaccines. Asia Pacific and Africa regions are projecting lucrative opportunity for foodborne diseases treatment market owing to increase in the incidence of foodborne diseases in these regions. According to WHO estimates 2015, Africa and South East Asia regions have the highest incidence and death rates, including children under the age of 5 years. Europe is expected to show significant growth rate owing to increase in R&D investment and healthcare spending.

 

Some of the market players in foodborne diseases treatment market are Bayer AG (Germany), Johnson & Johnson Services Inc., (U.S.), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), XOMA Corporation (U.S.), AlphaVax, Inc. (U.S.), Molecular Targeting Technologies, Inc. (U.S.), and Morphotek Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/

]]>
Global Foley Catheters Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:13:57 +0200 http://content.comunicati.net/comunicati/turismo/manifestazioni/481524.html http://content.comunicati.net/comunicati/turismo/manifestazioni/481524.html SAI SAI Global Foley Catheters Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Foley Catheters Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Foley catheter is also known as an indwelling catheter, which is inserted into bladder in order to drain the urine. It consists of a balloon which holds catheter inside the bladder at one of the end.  The balloon is filled with the sterile water for preventing the catheter from being removed from the bladder. The urine is drained into the collection tube through catheter. Foley catheters are used for long periods. These are used after the urological surgeries in order to help the patients to ease the urination in conditions like prostate hypertrophy nerve-related bladder dysfunction, narrowing of urethra and prostate cancer.

 

Foley Catheters market is anticipated to show significant growth during forecast period, due to increasing number of surgeries and rising demand of minimal invasive methods. In addition to this growing geriatric population and increasing demand for the sterile and disposable catheters, high reimbursement policies and technological advancements in the catheters are the factors which are fuelling the market growth. However, inadequate quality analysis and price sensitivity at domestic stages are hampering the market growth.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Global Foley Catheters market is segmented on the basis of type, material, end-user and geographical regions.

 

Based on the material, global foley catheters market is segmented as:

·         Latex

·         Silicone Elastomer Coated Latex

·         Silicone

·         Teflon Coated Latex

·         Hydrophilic Polymer Coated Latex

 

Based on the type, global foley catheters market is segmented as:

·         Indwelling catheter

·         Condom catheter

·         Intermittent catheters

 

Based on the end-user, global foley catheters market is segmented as:

·         Hospitals

·         Nursing Homes

·         Home care

·         Clinics

·         Ambulatory Surgical Centres

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-c654SbFYO64MsOhu

 

 

Globally, huge population is suffering with neurological, urological and cardiovascular, disorders who requires hospitalization in turn needs catheterization for the patients. As per World Health Organization (WHO), about 200 Mn people are suffering from the bladder control problems which require catheterization. As per the National Health Service (NHS) of UK, in 2013 imprecisely 3-6 Mn individuals are suffering from urinary incontinence in UK. Many market players are posing heavy investments in development of differencing products from the competitors’ products to enhance the competition, and players are focussing on the acquisitions, mergers and collaborations to enhance their market share.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-14mlyhjMGhVjZqa3

 

 

Based on the geographical regions, foley catheters market is segmented as Latin America, North America, Asia-Pacific, Europe and Middle East and Africa. North America has the dominating market shares in Foley Catheters Market followed by Europe, especially Germany dominates the market growth while UK is the speedy growing market in Foley catheters market. The Asia-Pacific is anticipated to have rapid growth in foresee period due to high government support, a large pool of geriatric population suffering from various urinary problems which requires immediate catheterization, rise in income levels, and widespread of awareness.

 

Some of the market players in foley catheters market are Coloplast A/S. (Denmark), B. Braun Melsungen AG (Germany), Becton Dickinson & Co (U.S.), Boston Scientific Corporation (U.S.), Teleflex Incorporation (U.S.), Medtronic (U.S), CooK Medical. (U.S.), Hollister Incorporated (U.S.) and TE Connectivity Corporation (Switzerland).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Feminine Hygiene Products Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:13:44 +0200 http://content.comunicati.net/comunicati/turismo/localita/milano_marittima/481523.html http://content.comunicati.net/comunicati/turismo/localita/milano_marittima/481523.html SAI SAI Global Feminine Hygiene Products Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Feminine Hygiene Products Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Feminine hygiene products are also called as menstrual hygiene products that are used as personal care products by menstruating women, some intersex people, transgender men, and non-binary people during menstrual cycle, during vaginal discharge, and other body functions which are related to the vulva and vagina. Sanitary napkins or towels, period panties, tampons, panty liners, and menstrual cups are the main categories in feminine hygiene products. Products which are meant to cleanse the area of vulva or inside the vagina, such as douche feminine deodorants, feminine wipes, feminine powders, and feminine soaps can also be considered as feminine hygiene products.

 

Feminine hygiene products market is expected to show a significant growth during the forecast period which attributes to the rise of disposable income per capita of many countries and changes in the lifestyle among the population globally, rise in awareness about female health and hygiene and an emergence of economic feminine hygiene products are the factors which are boosting the demand for feminine hygiene products. However, reports of women suffering with allergies and infections caused by the materials used in the manufacturing of  feminine hygiene products which are leading to the product recalls are the few  factors that are hindering the growth of the revenue of feminine hygiene products market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-feminine-hygiene-products-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The global feminine hygiene products market is segmented on the basis of product, distribution channel, and geographical regions.

 

Based on the product, the global feminine hygiene products market is segmented as:

·         Sanitary Pads

·         Tampons

·         Internal Cleansers and Sprays

·         Panty liners and Shields

·         Disposable Razors and Blades

 

Based on the distribution channels, the global feminine hygiene products market is segmented as:

·         Supermarkets

·         Drug stores

·         Pharmacies

·         Beauty Stores

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-feminine-hygiene-products-market/#ulp-c654SbFYO64MsOhu

 

 

Factors such as rise in usage of user-friendly feminine products such as reusable menstrual cups and pads, introducing of Bluetooth compatible and diagnostic tampons among middle-class consumers, use of chlorine-free cellulose and bio-degradable bio-plastic materials are enhancing the growth of the feminine hygiene products market. Several initiatives taken by the vendors by targeting women such as to educate them about the benefits by using the feminine hygiene products in order to improve the health and well-being of women. Initiatives taken by the majority of the governments in Asian countries to encourage woman hygiene such as in India, Total Sanitation Campaign (TSC) (1986) was introduced to promote hygiene and facilities of women sanitary health, and to construct toilets in schools. In 2015, UNICEF’s WASH program (Water, Sanitation, and Hygiene) was introduced to improve the hygiene conditions in rural regions.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-feminine-hygiene-products-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, the feminine hygiene products market is segmented into five regions, North America, Latin America, Middle East & Africa Europe and Asia-Pacific. Asia-Pacific is the largest market owing to large pool of population, rise in per capita income, increase in the number of working women, and rise in health awareness among women. India, China and Japan, are dominating the feminine hygiene products market in Asia-Pacific region. Rising awareness and easy availability of the feminine hygiene products is contributing the development of the feminine hygiene products market in the Middle East and Africa. North America and Europe is also having significant owing to the increase in demand for the innovative products like internal cleaners, sprays and tampons.

 

Some of the players in feminine hygiene products market are Kimberly-Clark Corporation (U.S.), Prestige Brands (U.S.), Edgewell Personal Care (U.S.), Procter & Gamble (U.S.), Lil-Lets Group Ltd. (UK), Unicharm Corporation (Japan), Glenmark Pharmaceuticals (India), and Hengan International Group Co. Ltd. (China).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-feminine-hygiene-products-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Extracorporeal Shock Wave Therapy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 15:13:31 +0200 http://content.comunicati.net/comunicati/turismo/manifestazioni/481522.html http://content.comunicati.net/comunicati/turismo/manifestazioni/481522.html SAI SAI Global Extracorporeal Shock Wave Therapy Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Extracorporeal Shock Wave Therapy Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Extracorporeal Shock Wave Therap Market (ESWT) is developed for the treatment of gall and kidney stones. Extracorporeal shock wave therapy has been used to treat rise in number of musculoskeletal conditions, like rotator cuff tendinitis, tennis elbow, patellar tendinopathy, plantar fasciitis, bony non-unions and Achilles tendinopathy. Shock wave therapy devices are non-invasive treatment for the musculoskeletal pain and can be used frequently in urology, physiotherapy, sports medicine, veterinary medicine and orthopaedics. It is also called as Extracorporeal Shock Wave Therapy (ESWT). Abrupt, high amplitude mechanical energy pulses are generated with help of the electromagnetic coil to manage and reduce the pain in ESWT process. ESWT is an alternative for surgery and also helps in speedy recovery of patients who are suffering from various tendon, muscle and joint disorders.

 

Rise in prevalence of arthritis and musculoskeletal disorders are the critical driving factors for the growth of the ESWT market. Demand for advance technological treatment for pain management and non-invasive nature of the therapy is the prime factors expected to drive the growth of ESWT market over the forecast period. ESWT helps in metabolic stimulation and increased cellular activity of the body which plays a major role in the rising demand for ESWT devices in the market.  As per the report given by the Population Reference Bureau, world’s population from 2016, is going to increase by 33% and estimated to reach 9.9 Bn by 2050 in which is mainly characterized by a large pool of geriatric population who are is highly prone to the wounds and injuries in turn creates a positive environment for the growth of global shock wave therapy devices market. On the other hand, lack of skilled professionals for the operation and handling of the device and high cost of the therapy may constrain the growth of the ESWT market over the forecast period.

ESWT market segmented on the basis of type, technology, and end user

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-extracorporeal-shock-wave-therapy-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

On the basis of type:

·         Mobile Shock Wave Therapy Devices

·         Fixed Shock Wave Therapy Devices

 

On the basis of technology:

·         Electromagnetic Technique

·         Electrohydraulic Technique

·         Piezoelectric Technique

·         Radial Technique

 

On the basis of application:

·         Kidney Stones

·         Pancreatic Stones

·         Uretic Stones

·         Salivary Stones

·         Musculoskeletal Disorders

 

On the basis of end-user:

·         Hospitals

·         Physiotherapy centres

·         Ambulatory surgical centers

·         Clinics

·         Radiology labs

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-extracorporeal-shock-wave-therapy-market/#ulp-c654SbFYO64MsOhu

 

 

ESWT market is expected to register a significant CAGR over a forecast period. As the sports-related injuries are common issues, ESWT market has gained more popularity by the sport clinicians and athletes. ESWT devices have received FDA-approval for lateral epicondylitis and plantar fasciitis. According to Health and Safety Executive, the UK, 41% of ill health was encountered among the UK employees due to work-related musculoskeletal disorders (WRMSD), accounting for around 1,311,000 cases in 2014. Furthermore, as per to the Centre for Disease Control about 22.7% of adults are diagnosed with various kind of arthritis, which is accounting around 54.4 million cases from 2013-2015. The high prevalence rate of musculoskeletal disorders creates a highly conducive environment for growth of shock wave therapy devices market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-extracorporeal-shock-wave-therapy-market/#ulp-14mlyhjMGhVjZqa3

 

 

Based on the geographical region, ESWT market is segmented as Latin America, North America, Asia Pacific, Europe, Middle East, and Africa. North America has the largest share in the global market, due to technological advancements and major investments in R&D of medical device technology. The Asia Pacific regions with emerging markets such as China and India are anticipated to show high growth in the market due to rise in population pool, changes in the lifestyle and healthcare infrastructure developments. Latin American countries like Brazil and Mexico have significant potential due to the evolving medical infrastructure.

 

Some of the players in the ESWT market are Dornier MedTech GmbH (Germany), Boston Scientific Corporation (U.S.), Cook Group Inc. (U.S.), C.R. Bard Inc. (U.S.), Medtrue Enterprise Co. Ltd. (U.K.), Olympus Corporation (Japan), Lumenis Ltd (Israel), Siemens AG (Germany), and Karl Storz GmbH (Germany)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-extracorporeal-shock-wave-therapy-market/

]]>
Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:26:23 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/pdl_partito_della_liberta/481486.html http://content.comunicati.net/comunicati/societa_civile/partiti/pdl_partito_della_liberta/481486.html SAI SAI Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The cancer biomarker test market is driven by rising prevalence of cancer worldwide. World Health Organization (WHO) stated that cancer is one of the leading causes of mortality and morbidity worldwide, with approximately 14 Mn new cases in 2012. The number of new cases is expected to rise about 70% over the coming 2 decades. In addition, increase in awareness in public and healthcare professionals regarding early diagnostic procedures, rise in government and NGO’s funding for oncology are expected to bolster the cancer biomarker testing market. Furthermore, the development of companion diagnostics and recent breakthrough in detection techniques such as proteomics, metabolomics, genomics and transcriptomics are further expected to boost the cancer biomarker test market. However, high cost for biomarker tests, low detection rates and regulatory policies are expected to hamper the cancer biomarker test market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-4H8Z4LpNMLEuOnnx

 

Cancer biomarker testing market segmented based on type of cancer, application, bio molecule and end user

Based on type of cancer, cancer biomarker test market is segmented into

·        Cervical cancer

·        Lung Cancer

·        Collateral Cancer

·        Liver Cancer

·        Prostate Cancer

·        Breast Cancer

·        Others

 

Based on application, cancer biomarker test market is segmented into

·        Drug Discovery and Development

·        Personalised Medicine

·        Diagnosis

·        Others

 

Based on end-user, cancer biomarker test market is segmented into

·        Hospitals

·        Cancer diagnostic Centres

·        Research Institutes

·        Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-c654SbFYO64MsOhu

 

The global cancer biomarker test market is expected to grow with significant CAGR during forecast period. Market players are carrying out collaborations, partnerships, and acquisitions as key development strategies to enhance the market share. For instance, in March 2017, Foundation Medicine and Bristol-Myers Squibb entered collaboration to understand tumour profile and its microenvironment to predict patient’s response to cancer immunotherapy. Using Foundation Medicine’s foundation genomic profiling assay, the firm will look at tumour mutational burden and microsatellite instability in patients enrolled in clinical trials for Bristol-Myers Squibb (BMS) cancer drugs. For instance, in October 2016, Arquer Diagnostics Ltd. (Arquer), and University of Sunderland are collaborated to investigate noninvasive specimen preparation techniques that will facilitate the use of Arquer’s MCM5-ELISA test in a wide range of cancers. In April 2016, Stemcentrix acquired by AbbiVe along with its lead late stage biomarker rovalpituzumab tesirine (Rova-T), that helps to identify tumour cells.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in cancer biomarker test market are Thermo Fisher Scientific  (Affymetrix Inc.) (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), and Hologic Inc. (U.S.) to name a few.

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:26:21 +0200 http://content.comunicati.net/comunicati/societa_civile/partiti/pdl_partito_della_liberta/481485.html http://content.comunicati.net/comunicati/societa_civile/partiti/pdl_partito_della_liberta/481485.html SAI SAI Global Cancer Biomarker Testing Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The cancer biomarker test market is driven by rising prevalence of cancer worldwide. World Health Organization (WHO) stated that cancer is one of the leading causes of mortality and morbidity worldwide, with approximately 14 Mn new cases in 2012. The number of new cases is expected to rise about 70% over the coming 2 decades. In addition, increase in awareness in public and healthcare professionals regarding early diagnostic procedures, rise in government and NGO’s funding for oncology are expected to bolster the cancer biomarker testing market. Furthermore, the development of companion diagnostics and recent breakthrough in detection techniques such as proteomics, metabolomics, genomics and transcriptomics are further expected to boost the cancer biomarker test market. However, high cost for biomarker tests, low detection rates and regulatory policies are expected to hamper the cancer biomarker test market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-4H8Z4LpNMLEuOnnx

 

Cancer biomarker testing market segmented based on type of cancer, application, bio molecule and end user

Based on type of cancer, cancer biomarker test market is segmented into

·        Cervical cancer

·        Lung Cancer

·        Collateral Cancer

·        Liver Cancer

·        Prostate Cancer

·        Breast Cancer

·        Others

 

Based on application, cancer biomarker test market is segmented into

·        Drug Discovery and Development

·        Personalised Medicine

·        Diagnosis

·        Others

 

Based on end-user, cancer biomarker test market is segmented into

·        Hospitals

·        Cancer diagnostic Centres

·        Research Institutes

·        Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-c654SbFYO64MsOhu

 

The global cancer biomarker test market is expected to grow with significant CAGR during forecast period. Market players are carrying out collaborations, partnerships, and acquisitions as key development strategies to enhance the market share. For instance, in March 2017, Foundation Medicine and Bristol-Myers Squibb entered collaboration to understand tumour profile and its microenvironment to predict patient’s response to cancer immunotherapy. Using Foundation Medicine’s foundation genomic profiling assay, the firm will look at tumour mutational burden and microsatellite instability in patients enrolled in clinical trials for Bristol-Myers Squibb (BMS) cancer drugs. For instance, in October 2016, Arquer Diagnostics Ltd. (Arquer), and University of Sunderland are collaborated to investigate noninvasive specimen preparation techniques that will facilitate the use of Arquer’s MCM5-ELISA test in a wide range of cancers. In April 2016, Stemcentrix acquired by AbbiVe along with its lead late stage biomarker rovalpituzumab tesirine (Rova-T), that helps to identify tumour cells.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-testing-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in cancer biomarker test market are Thermo Fisher Scientific  (Affymetrix Inc.) (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (U.S.), Arquer Diagnostics Ltd. (U.K.), Illumina, Inc. (U.S.), Qiagen (Germany), Agilent Technologies (U.S.), Merck & Co. Inc. (U.S.), Becton Dickinson and Company (U.S.), and Hologic Inc. (U.S.) to name a few.

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Breast Implants Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:25:29 +0200 http://content.comunicati.net/comunicati/arte/musica/pop/481484.html http://content.comunicati.net/comunicati/arte/musica/pop/481484.html SAI SAI Global Breast Implants Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

The breast implants treatment market is increasing at a significant CAGR due to increase in the female population. Rising prevalence of breast cancer cases, growing demand for cosmetic surgeries, and women with a high preference for improving aesthetic appeal might fuel the growth of the breast implants market over the forecast period. Moreover, an increase in the awareness about reconstructive breast surgeries, favorable demographics across the globe, and an increase in aging population are the key factors propelling the global breast implants market growth. However, increased risk of developing serious complications including deflation, capsular contracture, infection, and breast and nipple sensitivity, and high costs of the implant procedures are the major factors hampering the growth of the global breast implants market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast implants market is segmented on the basis of product type, application type, and end user

Based on product type, the breast implants market has been segmented into the following:

·        Silicone breast implants

·        Structured saline breast implants

·        Saline breast implants

·        Gummy bear breast implants

·        Round breast implants

·        Smooth breast implants

·        Textured breast implants

 

Based on treatment type, the breast implants market has been segmented into the following:

·        Reconstructive surgery

·        Cosmetic surgery

 

Based on the end user, the breast implants market has been segmented into the following:

·        Hospitals

·        Cosmetology clinics

·        Ambulatory surgical centres

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-c654SbFYO64MsOhu

 

Global breast implants market is in growing stage with the innovation of novel implants into the breast implants market. Increase in the prevalence of breast cancer cases, (according to World Health Organization every year around 200,000 new cases in women), growing preference for enhancing physical appearance might fuel the breast implants market. According to American Society of Plastic Surgeons (ASPS), breast augmentation surgeries were increased about 31% from 2000 to 2015. Launching of new products, innovation of less invasive surgical procedures, and product approvals from various regulatory bodies such as U.S. Food and Drug Administration might boost the breast implants market over the forecast period. For instance, in February 2013, FDA approved a silicone gel-filled breast implant manufactured by Allergan Plc, which uses more cohesive silicone gel, compared with previously approved breast implants. Similarly, In June 2013, the U.S. FDA has approved a silicone gel-filled breast implant which uses a more cohesive silicone gel manufactured by Mentor’s PMA, compared with their previously approved breast implants. Moreover, acquisitions and mergers, collaborations, and key licensing agreements also bolster the breast implants market growth. For instance, in December 2008, Johnson & Johnson has acquired breast-implant maker Mentor Corporation for the manufacturing of breast implants. In March 2015, Actavis plc has acquired of Allergan, Inc. to manufacture breast implants.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in the breast implants market are Allergan (U.S.), GC. Aesthetics (Ireland), Groupe Seb (France), Johnson & Johnson Services Inc.,(U.S.), Sientra, Inc. (U.S.), Polytech Health & Aesthetics GmbH (Germany), Establishment Labs S.A. (Costa Rica), Shanghai Kangning Medical Supplies Ltd. (China), Guangzhou Wanhe Plastic Materials Co., Ltd. (China), Laboratoires Arion (France), and Hansbiomed Co. Ltd (Korea).

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Breast Implants Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:25:26 +0200 http://content.comunicati.net/comunicati/arte/musica/pop/481483.html http://content.comunicati.net/comunicati/arte/musica/pop/481483.html SAI SAI Global Breast Implants Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

The breast implants treatment market is increasing at a significant CAGR due to increase in the female population. Rising prevalence of breast cancer cases, growing demand for cosmetic surgeries, and women with a high preference for improving aesthetic appeal might fuel the growth of the breast implants market over the forecast period. Moreover, an increase in the awareness about reconstructive breast surgeries, favorable demographics across the globe, and an increase in aging population are the key factors propelling the global breast implants market growth. However, increased risk of developing serious complications including deflation, capsular contracture, infection, and breast and nipple sensitivity, and high costs of the implant procedures are the major factors hampering the growth of the global breast implants market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast implants market is segmented on the basis of product type, application type, and end user

Based on product type, the breast implants market has been segmented into the following:

·        Silicone breast implants

·        Structured saline breast implants

·        Saline breast implants

·        Gummy bear breast implants

·        Round breast implants

·        Smooth breast implants

·        Textured breast implants

 

Based on treatment type, the breast implants market has been segmented into the following:

·        Reconstructive surgery

·        Cosmetic surgery

 

Based on the end user, the breast implants market has been segmented into the following:

·        Hospitals

·        Cosmetology clinics

·        Ambulatory surgical centres

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-c654SbFYO64MsOhu

 

Global breast implants market is in growing stage with the innovation of novel implants into the breast implants market. Increase in the prevalence of breast cancer cases, (according to World Health Organization every year around 200,000 new cases in women), growing preference for enhancing physical appearance might fuel the breast implants market. According to American Society of Plastic Surgeons (ASPS), breast augmentation surgeries were increased about 31% from 2000 to 2015. Launching of new products, innovation of less invasive surgical procedures, and product approvals from various regulatory bodies such as U.S. Food and Drug Administration might boost the breast implants market over the forecast period. For instance, in February 2013, FDA approved a silicone gel-filled breast implant manufactured by Allergan Plc, which uses more cohesive silicone gel, compared with previously approved breast implants. Similarly, In June 2013, the U.S. FDA has approved a silicone gel-filled breast implant which uses a more cohesive silicone gel manufactured by Mentor’s PMA, compared with their previously approved breast implants. Moreover, acquisitions and mergers, collaborations, and key licensing agreements also bolster the breast implants market growth. For instance, in December 2008, Johnson & Johnson has acquired breast-implant maker Mentor Corporation for the manufacturing of breast implants. In March 2015, Actavis plc has acquired of Allergan, Inc. to manufacture breast implants.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-implants-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in the breast implants market are Allergan (U.S.), GC. Aesthetics (Ireland), Groupe Seb (France), Johnson & Johnson Services Inc.,(U.S.), Sientra, Inc. (U.S.), Polytech Health & Aesthetics GmbH (Germany), Establishment Labs S.A. (Costa Rica), Shanghai Kangning Medical Supplies Ltd. (China), Guangzhou Wanhe Plastic Materials Co., Ltd. (China), Laboratoires Arion (France), and Hansbiomed Co. Ltd (Korea).

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Breast Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:25:07 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481482.html http://content.comunicati.net/comunicati/turismo/last_minute/481482.html SAI SAI Global Breast Cancer Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The global breast cancer treatment market is expected to increase with significant CAGR due to increasing prevalence and incidence of breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Moreover, the rise in the healthcare expenditure, increase in the diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco, and rising female population age of 65 years and above are expected to fuel the breast cancer treatment market over the forecast period. Furthermore, increase in the investments in research and developments, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology might boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market in the forecast years.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is segmented based on the treatment mechanism, treatment type, and distribution channel

Based on treatment mechanism, the breast cancer treatment market has been segmented into the following:

·        Local

·        Adjuvant

·        Neoadjuvant

·        Systemic

 

Based on drug class, the breast cancer treatment market has been segmented into the following:

·        Chemotherapy

·        Anthracyclines

·        Antimetabolites

·        Epothilones

·        Taxanes

·        Alkylating agents

·        Hormonal therapy

·        Aromatase inhibitors

·        Selective Oestrogen-receptor modulators

 

Based on the distribution channel, the breast cancer treatment market has been segmented into the following:

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

Global breast cancer treatment market is in developing stage, owing to increase in the prevalence rate of breast cancer disease. According to World Health Organization, about 2000 new cases in men and approximately 200,000 new breast cancer cases in women are diagnosed. Most of the pharmaceutical companies in breast cancer treatment market are focus on research and development activities, strategic collaborations, acquisitions & mergers, and product launches for the development of their revenue in the breast cancer treatment market. For instance, in March 2017, Novartis has received FDA approval for its drug kisqali (ribociclib, LEE011) used as first-line treatment for the HR+/HER2 metastatic breast cancer along with aromatase inhibitor. Similarly, In September 2013, The U.S. Food and Drug Administration granted the accelerated approval for Perjeta (pertuzumab) used in the treatment of early stage breast cancer treatment before surgery. The innovation of some innovative therapy with better success rate is expected to offer a good opportunity for breast cancer treatment market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

  

Some of the players in breast cancer treatment market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few.

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Breast Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:24:56 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481481.html http://content.comunicati.net/comunicati/turismo/last_minute/481481.html SAI SAI Global Breast Cancer Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The global breast cancer treatment market is expected to increase with significant CAGR due to increasing prevalence and incidence of breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Moreover, the rise in the healthcare expenditure, increase in the diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco, and rising female population age of 65 years and above are expected to fuel the breast cancer treatment market over the forecast period. Furthermore, increase in the investments in research and developments, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology might boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market in the forecast years.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is segmented based on the treatment mechanism, treatment type, and distribution channel

Based on treatment mechanism, the breast cancer treatment market has been segmented into the following:

·        Local

·        Adjuvant

·        Neoadjuvant

·        Systemic

 

Based on drug class, the breast cancer treatment market has been segmented into the following:

·        Chemotherapy

·        Anthracyclines

·        Antimetabolites

·        Epothilones

·        Taxanes

·        Alkylating agents

·        Hormonal therapy

·        Aromatase inhibitors

·        Selective Oestrogen-receptor modulators

 

Based on the distribution channel, the breast cancer treatment market has been segmented into the following:

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

Global breast cancer treatment market is in developing stage, owing to increase in the prevalence rate of breast cancer disease. According to World Health Organization, about 2000 new cases in men and approximately 200,000 new breast cancer cases in women are diagnosed. Most of the pharmaceutical companies in breast cancer treatment market are focus on research and development activities, strategic collaborations, acquisitions & mergers, and product launches for the development of their revenue in the breast cancer treatment market. For instance, in March 2017, Novartis has received FDA approval for its drug kisqali (ribociclib, LEE011) used as first-line treatment for the HR+/HER2 metastatic breast cancer along with aromatase inhibitor. Similarly, In September 2013, The U.S. Food and Drug Administration granted the accelerated approval for Perjeta (pertuzumab) used in the treatment of early stage breast cancer treatment before surgery. The innovation of some innovative therapy with better success rate is expected to offer a good opportunity for breast cancer treatment market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

  

Some of the players in breast cancer treatment market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few.

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Bionic Ears Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:24:37 +0200 http://content.comunicati.net/comunicati/arte/musica/rock/481480.html http://content.comunicati.net/comunicati/arte/musica/rock/481480.html SAI SAI  

Global Bionic Ears Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

A bionic ear is an electronic device that is designed by electrically stimulating nerves in the inner ear of deaf patients to produce hearing sensation. It consists of a receiver-stimulator implanted below patient’s skin behind the ear and sound processor. These processors stimulate the inner ear’s nerves which send signals to the brain where these signals are interpreted as sound. The bionic ear is beneficial for people who are suffering from severe, profound or total loss of hearing.

 

In the geriatric population, there has been a rapid rise in the prevalence of hearing disorders that will fuel the growth of bionic ears market. Hearing disabilities caused in new-born babies is a major cause of concern. Bionic ears are used to aid infants with hearing disabilities. Other factors such as availability of better infrastructure, better diagnostic facilities, increase in awareness among the population, and technological advancements in the field of bionic ears have positive influence on the market growth. Fear of malfunction of these devices and high cost associated are restricting the growth of bionic ears market. Furthermore, regulatory requirements for bionic ears also hampering the growth of the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-bionic-ears-market/#ulp-4H8Z4LpNMLEuOnnx

 

The global bionic ears Market can be segmented on the basis of device type, end user, and region.

On the basis of device type, global bionic ears market can be segmented into:

·        Bone Anchored Hearing Aid

·        Cochlear Implant

 

On the basis of the end -user, global bionic ears market can be segmented into:

·        Hospital

·        Hearing Clinics

·        Research Institutes

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-bionic-ears-market/#ulp-c654SbFYO64MsOhu

 

Standard hearing aid devices work by amplifying sound, but it is only useful for people with the partial loss of hearing not for people who are deaf or have profoundly impaired hearing. Loss of hearing is associated with the damage or other abnormalities in the tiny sensor hair cells present inside the cochlea or inner ear. To overcome such conditions bionic ears are used. Bionic ears market is expected to show considerable growth over the forecast period. As per WHO, more than 360 Mn people are affected by loss of hearing disability globally. Loss of hearing is one of the leading global disorder. According to the Royal National Institute for Deaf People (RNID), the prevalence rate of hearing disorder is growing with the age, which is affecting about 70% of people over 70 and 42% people over 50.Geriatric people are highly susceptible to loss of hearing that can affect their social life. Due to this factor, bionic ear market is expected show significant growth. Untreated loss of hearing among newborn can affect their entire life. As it can lead to impairment in speaking and affect their psychological abilities. But due to technological advancement and development of bionic ears, it is now possible to help these children.  Also due to increasing awareness and better diagnostic facilities to detect the problem number of cases are being registered among newborn children. Research institutes such as Bionics Institute are aiming at improving the performance of bionic ears and function of hearing nerves.

Based on the geographical regions, global bionic ears market can be segmented into North America, Europe, Latin America, Asia-Pacific, and Middle East & Africa. The largest share in the bionic ears market is held by the North America. It is mainly attributed due to the better diagnostic facilities and increase in awareness among the people about hearing disorders in this region. Europe and Asia-Pacific stand next to North America this is mainly due to the large patient population, vast technological advancements in bionic ears, and increase in income of the individuals. Countries such as China, Japan, and India in Asia Pacific and Germany, the U.K., Italy, Spain, and France in Europe are at the forefront of the market growth in these regions.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-bionic-ears-market/#ulp-14mlyhjMGhVjZqa3

  

Some of the major participants in the bionic ears market are Sivantos Pvt. Ltd. (South Korea), Cochlear Ltd. (Australia), William Demant Holdings (Denmark), Terumo Corporation (Japan), EKSO Bionics (U.S), Advanced Bionics AG (Switzerland), Sonova (Switzerland),  MED-EL (Austria), LifeNet Health (U.S), Össur (U.S)., Nano Retina Inc.(Israel).

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

PrecIsion Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>